‘Autism and ADHD: diagnosis and demand in neurodevelopmental care’, The 2026 Emanuel Miller International Online Conference will explore current debates around autism and ADHD, focusing on how scientific evidence, diagnostic practices, and rising demand for assessment intersect within contemporary neurodevelopmental care. Bringing together leading experts, the programme will examine how changes in diagnostic frameworks, service pressures, and social contexts shape who receives a diagnosis, when, and with what implications for young people, families, and services. The conference aims to provide a reflective, evidence-informed space to critically engage with questions of diagnosis, demand, and care across different clinical and service contexts.
Confirmed speakers; Professor Sam Cortese, Professor Jonathan Green, Professor Will Mandy, Professor Petrus de Vries, Professor Stephen Hinshaw.
Booking
Sign up at this link or on the Book Now button at the top of the screen, and complete the form that follows. You’ll then receive an email confirmation and a link to the webinar, plus we’ll send you a calendar reminder nearer the time. Delegates will have exclusive access to recordings for 90 days after the event, together with slides. Plus you will get a personalised CPD/CME certificate via email.
- ACAMH Members MUST login to book onto the webinar in order to access this webinar and get a CPD/CME certificate
- Non-members this is a great time to join ACAMH, take a look at what we have to offer, and make the saving on these sessions
EARLY BIRD £99 (until 16/03/26, then £149) for ACAMH Members (Print, Online, Concession) Join now and save
EARLY BIRD £139 (until 16/03/26, then £199) ACAMH Learn Account holders
EARLY BIRD £139 (until 16/03/26, then £199) Non Members
£15 ACAMH Undergraduate/Postgraduate Members
FREE LMIC Members
Don’t forget as a charity any surplus made is reinvested back as we work to our vision of ‘Sharing best evidence, improving practice’, and our mission to ‘Improve the mental health and wellbeing of young people aged 0-25’.
About the speakers
Professor Samuele Cortese, MD, PhD is currently a National Institute for Health and Care Research (NIHR) Research Professor; Professor of Child and Adolescent Psychiatry at the University of Southampton; and Honorary Consultant for the Hampshire and Isle of Wight Healthcare National Health Service (NHS) Foundation Trust, United Kingdom. Prof. Cortese’s main research interests focus on neurodevelopmental disorders. He has published more than 450 peer-reviewed papers and has secured more than £23 million in funding as a principal or co-applicant. Since 2022, he has been included in the top 1% of scientists in the field of psychiatry and psychology (Clarivate- Web of Science) and has been ranked #1 worldwide for expertise in Attention-Deficit/Hyperactivity Disorder (ADHD) and neurodevelopmental disorders (Expertscape). Prof. Cortese sat on the Attention-Deficit/Hyperactivity Disorder NHS Taskforce and has been a member of the National Institute for Health and Care Excellence (NICE) committee on Digital Technologies for Assessing Attention-Deficit/Hyperactivity Disorder.
Jonathan Green is Professor of Child and Adolescent Psychiatry at University of Manchester and Hon Consultant Child and Adolescent Psychiatrist at the Royal Manchester Children’s Hospital. He studied medicine at Cambridge, Paediatrics in London and Psychiatry in Oxford before establishing clinical and research groups in Manchester, UK. He has focused clinically and in research on early social and relational development in children generally, and on autistic development in particular. His group has led development and testing of early parent-mediated interventions for autistic development for both pre-school diagnosed children (PACT) and in the pre-diagnostic stage (iBASIS); and built on this evidence to advocate an early developmental pathway approach to autistic care that is now being applied in UK and internationally. In the last few years, he has undertaken increasing participatory work with the autistic community, including discussion on neurodiversity and the ethics of intervention, explorations of autistic phenomenology and full co-design of a new anxiety intervention for young autistic children. Jonathan sat on the most recent UK NICE development group for autism. He is a Senior Investigator in NIHR, Fellow of the UK Academy of Medical Sciences, and UK Global Senior Leader for autism for the International Society of Autism Research (INSAR).